Aspect Partners’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.38K Sell
99
-22
-18% -$1.77K ﹤0.01% 317
2026
Q1
$8.56K Hold
121
﹤0.01% 290
2025
Q4
$9.55K Buy
121
+9
+8% +$712 ﹤0.01% 278
2025
Q3
$9.22K Buy
112
+22
+24% +$1.73K ﹤0.01% 315
2025
Q2
$7.24K Hold
90
﹤0.01% 326
2025
Q1
$7.23K Sell
90
-2
-2% -$166 ﹤0.01% 301
2024
Q4
$7.53K Sell
92
-9
-9% -$749 ﹤0.01% 318
2024
Q3
$8.33K Hold
101
﹤0.01% 294
2024
Q2
$7.09K Hold
101
﹤0.01% 306
2024
Q1
$7.49K Hold
101
0.01% 302
2023
Q4
$6.68K Buy
+101
New +$6.32K ﹤0.01% 302

Other funds holding MET

Aspect Partners's MET Position: Q2 2026 in Review

Aspect Partners reduced its MetLife (MET) stake by 18% in Q2 2026, selling an estimated $1.77K and leaving 99 shares worth $8.38K. The position accounts for ﹤0.01% of the portfolio, ranked #317.

Aspect Partners first reported a position in MET in Q4 2023 and has held it in 11 quarters since. The position peaked at $9.55K in Q4 2025. 1,445 funds tracked by Wall St. Rank hold MET as of Q2 2026.

  • Aspect Partners held 99 shares of MetLife worth $8.38K as of Q2 2026.
  • Aspect Partners sold 22 MetLife shares in Q2 2026, an estimated $1.77K.
  • MetLife made up ﹤0.01% of Aspect Partners's portfolio in Q2 2026, its #317 holding.
  • Aspect Partners first reported a position in MetLife in Q4 2023 and has held it in 11 quarters since.
  • Aspect Partners's MetLife position peaked at $9.55K in Q4 2025.
  • 1,445 funds tracked by Wall St. Rank held MetLife as of Q2 2026.

Based on Aspect Partners's 13F filing for Q2 2026, filed 16 Jul 2026.